Polymerase Chain Reaction for Case Ascertainment of Meningococcal Meningitis: Application to the Cerebrospinal Fluids Collected in the Course of the Norwegian Meningococcal Serogroup B Protection Trial

References

• Fredriksen J H, Rosenqvist E, Wedege E, Bryn K, Bjune G, Frøholm L O, Lindbak A-K, Møgster B, Namork E, Rye U, Stabbetorp G, Winsnes R, Aase B, Closs O. Production, characterization and control of MenB-vaccine ‘Folkehelsa’: an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann (Oslo) 1991; 14: 67–79
   PubMedGoogle Scholar
• Bjune G, Høiby E A, Grønnesby J K, Arnesen ø, Fredriksen J H, Halstensen A, Holten E, Lindbak A-K, Nøkleby H, Rosenqvist E, Solberg L K, Closs O, Eng J, Frøholm L O, Lystad A, Bakketeig L S, Hareide B. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 1991; 338: 1093–1096
   PubMed Web of Science ®Google Scholar
• Harthug S, Rosenqvist E, Høiby E A, Gedde-Dahl T W, Frøholm L O. Antibody response in group B meningococcal disease determined by enzyme-linked immunoabsorbent assay with serotype 15 outer membrane antigen. J Clin Microbiol 1986; 24: 947–953
   PubMedGoogle Scholar
• Høiby E A, Bjune G, Frøholm L O, Eng J, Halstensen A, Rosenqvist E, Rønnild E, Wedege E. The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and sero-logical diagnosis. NIPH Ann (Oslo) 1991; 14: 107–123
   PubMedGoogle Scholar
• Høiby E A, Bruun J B, Andrew M, Bøvre K, Brandtzæg P, Halstensen A, Bjorvatn B, Borchgrevink H M, Gedde-Dahl T W, Jacobsen S, Myhre E, Steen-Johnsen J. Guidelines for diagnosis and treatment of meningococcal disease [in Norwegian]. Norwegian Board of Health, Oslo 1989; 77
   Google Scholar
• Gedde-Dahl T W, Høiby E A, Brandtzæg P, Eskerud J R, Bøvre K. Some arguments on early hospital admission and treatment of suspected meningococcal disease cases. NIPH Ann (Oslo) 1990; 13: 45–60
   PubMedGoogle Scholar
• Cartwright K, Reilly S, White D, Stuart J. Early treatment with parenteral penicillin in meningococcal disease. Br Med J 1992; 305: 143–147
   PubMed Web of Science ®Google Scholar
• Kristiansen B-K, Ask E, Jenkins A, Fermér C, Rådstrøm P, Skøld O. Rapid diagnosis of meningococcal meningitis by polymerase chain reaction. Lancet 1991; 337: 1568–1569
   PubMed Web of Science ®Google Scholar
• Ni H, Knight A J, Cartwright K, Palmer W H, McFadden J. Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet 1992; 340: 1432–1434
   PubMed Web of Science ®Google Scholar
• McLaughlin G L, Howe D K, Biggs D R, Smith A R, Ludwinski P, Fox B C, Tripathy D N, Frasch C E, Wenger J D, Carey J D, Hassan-King M, Vodkin M H. Amplification of rDNA loci to detect and type Neisseria meningitidis and other eubacteria. Mol Cell Probes 1993; 7: 7–17
   PubMedGoogle Scholar
• Saunders N, Zollinger W D, Rao V D. A rapid and sensitive PCR strategy employed for amplification and sequencing of por A from a single colony-forming unit of Neisseria meningitidis. Gene 1993; 137: 153–162
   PubMed Web of Science ®Google Scholar
• Rådstrøm P, Bäckman A, Qian N, Kragsbjerg P, Påhlson C, Olcén P. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis. Haemophilus influenzae, and streptococci using a seminested PCR strategy. J Clin Microbiol 1994; 32: 2738–2744
   PubMed Web of Science ®Google Scholar
• Wedege E, Dalseg R, Caugant D A, Poolman J T, Frøholm L O. Expression of an inaccessible PI.7 subtype epitope on meningococcal class 1 proteins. J Med Microbiol 1993; 38: 23–28
   PubMedGoogle Scholar
• McGuinness B T, Lambden P R, Heckels J E. Class 1 outer membrane proteins of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol Microbiol 1993; 7: 505–514
   PubMedGoogle Scholar
• Wedege E, Kolberg J, Delvig A, Høiby E A, Holten E, Rosenqvist E, Caugant D A. Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in Norway. Clin Diagn Lab Immunol 1995; 2: 314–321
   PubMedGoogle Scholar
• Brandtzæg P, Kierulf P, Gaustad P, Skulberg A, Bruun J N. Halvorsen S, Sørensen S. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195–204
   PubMed Web of Science ®Google Scholar
• Caugant D A, Frøholm L O, Bøvre K, Holten E, Frasch C E, Mocca L F, Zollinger W D, Selander R K. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci USA 1986; 83: 4927–4931
   PubMed Web of Science ®Google Scholar
• Frøholm L O, Caugant D A, Aasen S, Holten E. Recent meningococcal epidemiology in Norway. Eight years of serotyping for strain characterization. Neisseriae 1990, M Achtman, C Marchal, G Morelli, A Seiler, B Thiesen. Walter de Gruyter, Berlin 1991; 57–61
   Google Scholar
• Brandtzæg P, Øvstebø R, Kierulf P. Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis 1992; 166: 650–652
   PubMed Web of Science ®Google Scholar
• Caugant D A, Høiby E A, Rosenqvist E, Frøholm L O, Selander R K. Transmission of Neisseria meningitidis among asymptomatic military recruits and antibody analysis. Epidemiol Infect 1992; 109: 241–253
   PubMed Web of Science ®Google Scholar
• Frøholm L O, Caugant D A, Holten E, Høiby E A, Rosenqvist E, Wedege E. Meningococcal strains isolated from teenage patients during the serogroup B vaccination trial in Norway: serotyping, serosubtyping, immunotyping and clonal analysis. NIPH Ann (Oslo) 1991; 14: 139–146
   PubMedGoogle Scholar